These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17455802)

  • 1. The mechanisms of activation of normal human serum complement by Escherichia coli strains with K1 surface antigen.
    Bugla-Płoskońska G; Cisowska A; Karpińska K; Jankowski S; Doroszkiewicz W
    Folia Microbiol (Praha); 2006; 51(6):627-32. PubMed ID: 17455802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sensitivity of escherichia coli strains with K1 surface antigen and rods without this antigen to the bactericidal effect of serum.
    Cisowska A; Jankowski S
    Folia Microbiol (Praha); 2004; 49(4):471-8. PubMed ID: 15530015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. K1, K5 and O antigens of Escherichia coli in relation to serum killing via the classical and alternative complement pathways.
    Devine DA; Roberts AP
    J Med Microbiol; 1994 Aug; 41(2):139-44. PubMed ID: 7519270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of ozone on the susceptibility of Escherichia coli K1 to the bactericidal action of serum.
    Jankowski S; Cisowska A; Doroszkiewicz W
    Folia Microbiol (Praha); 1996; 41(5):395-400. PubMed ID: 9131796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of cefotaxime and normal human serum on bactericidal activity against urinary strains of Escherichia coli with capsular antigen K1.
    Franiczek R; Jankowski S
    Acta Microbiol Pol; 1993; 42(3-4):243-50. PubMed ID: 7516615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degree of antibody-independent activation of the classical complement pathway by K1 Escherichia coli differs with O antigen type and correlates with virulence of meningitis in newborns.
    Pluschke G; Achtman M
    Infect Immun; 1984 Feb; 43(2):684-92. PubMed ID: 6198283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The classical complement pathway plays a critical role in the opsonisation of uropathogenic Escherichia coli.
    Li K; Sacks SH; Sheerin NS
    Mol Immunol; 2008 Feb; 45(4):954-62. PubMed ID: 17870166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative contribution of ColV plasmid and K1 antigen to the pathogenicity of Escherichia coli.
    Agüero ME; Cabello FC
    Infect Immun; 1983 Apr; 40(1):359-68. PubMed ID: 6339405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased Ficolin-3-mediated Complement Lectin Pathway Activation and Alternative Pathway Amplification During Bacterial Infections in Patients With Type 2 Diabetes Mellitus.
    Barkai LJ; Sipter E; Csuka D; Prohászka Z; Pilely K; Garred P; Hosszúfalusi N
    Front Immunol; 2019; 10():509. PubMed ID: 30949171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the capsule and the O antigen in resistance of O18:K1 Escherichia coli to complement-mediated killing.
    Pluschke G; Mayden J; Achtman M; Levine RP
    Infect Immun; 1983 Dec; 42(3):907-13. PubMed ID: 6196296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of growth temperature of Escherichia coli on K1 capsular antigen production and resistance to opsonization.
    Bortolussi R; Ferrieri P; Quie PG
    Infect Immun; 1983 Mar; 39(3):1136-41. PubMed ID: 6341228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Lectin Complement Pathway Is Involved in Protection Against Enteroaggregative
    Adler Sørensen C; Rosbjerg A; Hebbelstrup Jensen B; Krogfelt KA; Garred P
    Front Immunol; 2018; 9():1153. PubMed ID: 29896194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of K1, K5 and O antigens in Escherichia coli isolates from patients with urinary tract infections or bacteraemia.
    Devine DA; Robinson L; Roberts AP
    J Med Microbiol; 1989 Dec; 30(4):295-9. PubMed ID: 2481040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bactericidal, bacteriolytic and opsonic activity of human serum against Escherichia coli.
    Rozenberg-Arska M; Porsius JC; Jaarsma EY; Verhoef J
    J Med Microbiol; 1986 Sep; 22(2):143-9. PubMed ID: 3528498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the SDS-PAGE patterns of outer membrane proteins from Escherichia coli strains that have lost the ability to form K1 antigen and varied in the susceptibility to normal human serum.
    Cisowska A; Bugla-Płoskońska G
    Folia Microbiol (Praha); 2014 Jan; 59(1):37-43. PubMed ID: 23794053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic bactericidal effect of cephalexin and normal cord serum (NCS) against Escherichia coli K1 strains isolated from children with urinary tract infections (UTI).
    Cisowska A; Jankowski S; Doroszkiewicz W
    Acta Microbiol Pol; 1999; 48(4):381-3. PubMed ID: 10756721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of Escherichia coli with capsular antigen K1 isolated from urinary tract infection on the joint action of cefotaxime and normal human serum.
    Jankowski S; Franiczek R
    Nephron; 1994; 68(4):519-20. PubMed ID: 7870242
    [No Abstract]   [Full Text] [Related]  

  • 19. Sialic acid-containing lipopolysaccharides of Salmonella O48 strains--potential role in camouflage and susceptibility to the bactericidal effect of normal human serum.
    Bugla-Płoskońska G; Rybka J; Futoma-Kołoch B; Cisowska A; Gamian A; Doroszkiewicz W
    Microb Ecol; 2010 Apr; 59(3):601-13. PubMed ID: 19844648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Logarithmic phase Escherichia coli K1 efficiently avoids serum killing by promoting C4bp-mediated C3b and C4b degradation.
    Wooster DG; Maruvada R; Blom AM; Prasadarao NV
    Immunology; 2006 Apr; 117(4):482-93. PubMed ID: 16556262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.